Evaluation of the Effectiveness of Enhanced Recovery After Surgery (ERAS) Program in Pediatric Lung Surgery

November 16, 2025 updated by: National Taiwan University Hospital
This study aims to evaluate the clinical effectiveness of the Enhanced Recovery After Surgery (ERAS) program for pediatric lung surgery at our institution.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Using a prospective cohort design, we will observe pediatric patients undergoing lung surgery following the implementation of the ERAS program as standard practice. Outcomes will be compared with a historical control group (2014-2023) to assess whether ERAS reduces hospital length of stay, lowers postoperative complication rates, accelerates recovery, and decreases healthcare costs.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
    • Taiwan
      • Taipei, Taiwan, Taiwan
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Pediatric patients aged 0 to 18 years who underwent lung surgery at our institution. Eligible procedures were identified using treatment thoracoscopic lobectomy, thoracoscopic wedge or partial resection, and thoracoscopic segmentectomy.

Description

Inclusion Criteria:

  • Children who underwent lung surgery at our hospital's Division of Pediatric Surgery

Exclusion Criteria:

  • Patients who underwent multiple surgeries (including surgeries other than lung surgery) during the same hospitalization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Enhanced Recovery After Surgery, ERAS
During the study period, all enrolled patients will be managed according to our institution's consensus ERAS checklist for pediatric lung surgery.
Other: Enhanced Recovery After Surgery, ERAS
During the study period, all enrolled patients will be managed according to our institution's consensus checklist for pediatric lung surgery ERAS care. This includes ERAS education, preoperative assessment, fasting guidance, prophylaxis for nausea and vomiting, standardized anesthesia and surgical protocols, preference for minimally invasive surgery, multimodal postoperative analgesia, and encouragement of early oral intake and mobilization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay
Time Frame: Up to 30 days after surgery.
Number of days from index operation to hospital discharge
Up to 30 days after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: Within 30 days after surgery.
Incidence of postoperative complications, including prolonged air leak, pneumonia, surgical site infection, and other procedure-related events.
Within 30 days after surgery.
Duration of urinary catheter placement
Time Frame: From date of surgery to catheter removal (up to 30 days)
Number of days with indwelling urinary catheter postoperatively.
From date of surgery to catheter removal (up to 30 days)
Duration of chest tube drainage
Time Frame: From date of surgery to chest tube removal (up to 30 days).
Number of days with thoracic drainage tube postoperatively.
From date of surgery to chest tube removal (up to 30 days).
Intensive care unit stay
Time Frame: From date of ICU admission to transfer out (up to 30 days).
Number of days in ICU after surgery.
From date of ICU admission to transfer out (up to 30 days).
Postoperative pain
Time Frame: Daily assessment up to 7 days postoperatively.
Pain intensity assessed by numeric rating scale (NRS)
Daily assessment up to 7 days postoperatively.
Postoperative analgesic use
Time Frame: Daily assessment up to 7 days postoperatively.
Total analgesic consumption.
Daily assessment up to 7 days postoperatively.
30-day readmission or emergency department visit
Time Frame: Within 30 days post-discharge.
Incidence of unplanned readmission or emergency department visit within 30 days after discharge.
Within 30 days post-discharge.
Time to resumption of oral intake
Time Frame: From date of surgery to initiation of oral intake (up to 7 days).
Interval from surgery to first tolerated oral feeding.
From date of surgery to initiation of oral intake (up to 7 days).
Hospital cost
Time Frame: From date of admission to discharge, up to 30 days
Total hospitalization cost during the index admission.
From date of admission to discharge, up to 30 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
ERAS protocol adherence rate
Time Frame: Up to 30 days after surgery
Proportion of ERAS protocol elements implemented per patient compared to total eligible elements.
Up to 30 days after surgery
Patient satisfaction with ERAS program
Time Frame: Up to 30 days after surgery.
Satisfaction assessed by structured questionnaire at discharge.
Up to 30 days after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2025

Primary Completion (Estimated)

February 28, 2030

Study Completion (Estimated)

February 28, 2030

Study Registration Dates

First Submitted

October 2, 2025

First Submitted That Met QC Criteria

November 16, 2025

First Posted (Actual)

November 21, 2025

Study Record Updates

Last Update Posted (Actual)

November 21, 2025

Last Update Submitted That Met QC Criteria

November 16, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202504141RINE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pediatric

Clinical Trials on Enhanced Recovery After Surgery, ERAS

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe